Publications by authors named "Dawn Goodridge"

Claim this Profile
A
A Phase II Trial of Selinexor (KPT-330) for Metastatic Triple-Negative Breast Cancer.
Michael Shafique, Roohi Ismail-Khan, Martine Extermann, Dan Sullivan, Dawn Goodridge

Oncologistยท July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis